13F-HR/A filed by Kestra Advisory Services, LLC
Kestra Advisory Services, LLC filed this 13F-HR/A for the quarter ended 2021-12-31, filed 2022-07-25, with 2,004 holding rows worth $9,879,375,000.
- Accession
- 0001830819-22-000005
- Filer
- CIK 1830819
- Filed
- 2022-07-25
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, amendment of type restatement, 2,004 entries on the cover page, a total value of $9,879,375,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $9,879,375,000 with VALUE read as thousands by filing date, 13F file number 028-20379. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CALITHERA BIOSCIENCES INC COM NEW | 13089P101 | Stock | 20,000 | $13,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 10,000 | $12,000 | thousands by filing date | |
| CORBUS PHARMACEUTICALS HLDGS | 21833P103 | COM | 19,250 | $12,000 | thousands by filing date | |
| ELECTROCORE INC | 28531P103 | COM | 13,542 | $8,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001830819-22-000001 | superseded | 2022-01-20 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001830819-22-000005 | this filing | 2022-07-25 | acceptance time not in the bulk data set |